In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors

Citation
T. Muzzammil et al., In vitro comparison of sestamibi, tetrofosmin, and furifosmin as agents for functional imaging of multidrug resistance in tumors, CANC BIO R, 15(4), 2000, pp. 339-346
Citations number
26
Categorie Soggetti
Oncology,"Onconogenesis & Cancer Research
Journal title
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
ISSN journal
10849785 → ACNP
Volume
15
Issue
4
Year of publication
2000
Pages
339 - 346
Database
ISI
SICI code
1084-9785(200008)15:4<339:IVCOST>2.0.ZU;2-J
Abstract
Sestamibi, tetrofosmin, and furifosmin are Tc-99m-labeled myocardial perfus ion imaging agents which have been shown to be substrates for P-glycoprotei n (Pgp), the multidrug-resistance transporter which is overexpressed in som e tumors. The three tracers were directly compared in vitro in the human br east cancer cell line MCF7-WT and two multidrug-resistant variants, MCF7-BC 19 (MDR1 gene transfected) and MCF7-AdrR (doxorubicin selected). Tracer acc umulation over the course of 60 minutes was determined Dose-response curves were generated for two modulators of Pgp function, GG918 and PSC833. The g eneral shape of accumulation curves for the three tracers in MCF7-WT cells was similar, with accumulation levels being sestamibi > tetrofosmin >furifo smin. Accumulation of sestamibi and furifosmin in MCF7-BC19 cells was reduc ed to 10% and 21% of MCF7-WT levels, respectively, but this accumulation de ficit could be completely reversed by addition of 0.1 mu M GG918 or 2 mu MP SC833. Accumulation of sestamibi and tetrofosmin in MCF7-AdrR cells was 1.6 % and 12% of MCF7-WT levels, respectively. and could only be enhanced to 30 % and 45% of MCFT-WT levels by addition of GG918 or PSC833. In contrast fur ifosmin showed similar levels of accumulation in MCF7-WT and MCF7-BC19 cell s, slightly lower levels in MCF7-AdrR cells, and no consistent response to Pgp modulators. These results support the continued investigation of sestam ibi and tetrofosmin as agents for functional imaging of multidrug resistanc e in human cancer.